ClearPoint Neuro, Inc.
CLPT
$17.98
-$0.55-2.97%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.13M | 10.41M | 8.86M | 9.22M | 8.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.13M | 10.41M | 8.86M | 9.22M | 8.49M |
| Cost of Revenue | 4.37M | 4.01M | 3.26M | 3.66M | 3.35M |
| Gross Profit | 7.76M | 6.40M | 5.60M | 5.56M | 5.13M |
| SG&A Expenses | 11.71M | 8.41M | 7.42M | 7.41M | 7.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.61M | 15.66M | 14.14M | 14.90M | 14.65M |
| Operating Income | -8.48M | -5.25M | -5.28M | -5.68M | -6.16M |
| Income Before Tax | -9.54M | -7.78M | -5.88M | -5.81M | -6.01M |
| Income Tax Expenses | 8.00K | 4.00K | 8.00K | 25.00K | 18.00K |
| Earnings from Continuing Operations | -9.55M | -7.79M | -5.89M | -5.84M | -6.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.55M | -7.79M | -5.89M | -5.84M | -6.03M |
| EBIT | -8.48M | -5.25M | -5.28M | -5.68M | -6.16M |
| EBITDA | -8.19M | -4.93M | -5.21M | -5.28M | -6.06M |
| EPS Basic | -0.32 | -0.27 | -0.21 | -0.21 | -0.22 |
| Normalized Basic EPS | -0.20 | -0.13 | -0.13 | -0.13 | -0.14 |
| EPS Diluted | -0.32 | -0.27 | -0.21 | -0.21 | -0.22 |
| Normalized Diluted EPS | -0.20 | -0.13 | -0.13 | -0.13 | -0.14 |
| Average Basic Shares Outstanding | 29.55M | 28.85M | 28.43M | 28.26M | 27.72M |
| Average Diluted Shares Outstanding | 29.55M | 28.85M | 28.43M | 28.26M | 27.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |